Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Judith A. Rodrigo"'
Autor:
Natasha Kekre, Kevin A. Hay, John R. Webb, Ranjeeta Mallick, Miruna Balasundaram, Mhairi K. Sigrist, Anne-Marie Clement, Julie S. Nielsen, Jennifer Quizi, Eric Yung, Scott D. Brown, Lisa Dreolini, Daniel D. Waller, Julian Smazynski, Nicole S. Gierc, Bianca C. Loveless, Kayla Clark, Tyler Dyer, Richard Hogg, Leah McCormick, Michael Gignac, Shanti Bell, D. Maria Chapman, David Bond, Siao Yong, Rachel Fung, Heather M. Lockyer, Victoria Hodgson, Catherine Murphy, Ana Subramanian, Evelyn Wiebe, Piriya Yoganathan, Liana Medynski, Dominique C. Vaillan, Alice Black, Sheryl McDiarmid, Michael Kennah, Linda Hamelin, Kevin Song, Sujaatha Narayanan, Judith A. Rodrigo, Stefany Dupont, Terry Hawrysh, Justin Presseau, Kednapa Thavorn, Manoj M. Lalu, Dean A. Fergusson, John C. Bell, Harold Atkins, Brad H. Nelson, Robert A. Holt
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Access to commercial CD19 CAR-T cells remains limited even in wealthy countries like Canada due to clinical, logistical, and financial barriers related to centrally manufactured products. We created a non-commercial academic platform for end-to-end m
Externí odkaz:
https://doaj.org/article/ba9bb5ccb69a4646aee78f29aa8e0137
Publikováno v:
Cankaya University Journal of Humanities and Social Sciences. 16:43-60
The comic series, the Adventures of Asterix created by René Goscinny and Albert Uderzo became exceptionally popular in Sri Lanka in the early 2000s when the local TV channel Sirasa broadcasted the animated films dubbed in Sinhala. The present paper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e407e38756b5e5c64eec79a4b638fa0b
https://doi.org/10.47777/cankujhss.1025890
https://doi.org/10.47777/cankujhss.1025890
Autor:
Bo Wan, Lorenzo Lindo, Giovanna Cameron, Yasser Abou Mourad, Shanee Chung, Donna L. Forrest, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse Power, Judith A Rodrigo, David Sanford, Kevin Song, Ryan J Stubbins, Heather J. Sutherland, Cynthia L. Toze, Jennifer K. White, Claudie Roy, Kevin A. Hay
Publikováno v:
Blood. 140:7555-7557
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2422bbeb0375da680f7033048356074
https://doi.org/10.1182/blood-2022-163594
https://doi.org/10.1182/blood-2022-163594
Autor:
Jessica L. Bazin, Yasser Abou Mourad, Donna L. Forrest, Kevin Hay, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse Power, Judith A Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J. Stubbins, Heather J. Sutherland, Cynthia L. Toze, Jennifer White, Shanee Chung
Publikováno v:
Blood. 140:7718-7720
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37444827875d371c2d8af2784e01acca
https://doi.org/10.1182/blood-2022-165411
https://doi.org/10.1182/blood-2022-165411
Autor:
Donna L. Forrest, Thomas J. Nevill, Jennifer White, Judith Anula Rodrigo, Florian Kuchenbauer, Shanee Chung, Kevin A. Hay, Heather J. Sutherland, Cynthia L. Toze, David Sanford, Kevin W. Song, Yasser Abou Mourad, Stephen H. Nantel, Sujaatha Narayanan, Maryse M. Power
Publikováno v:
Blood. 138:3935-3935
Introduction: Patients newly diagnosed with classic Hodgkin lymphoma (CHL) have over 80% chance of remission with first-line chemotherapy, such as ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) regime. However, 10-40% of patients relapse even
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::458e97e12fcac25145a4243b0f342a93
https://doi.org/10.1182/blood-2021-154492
https://doi.org/10.1182/blood-2021-154492
Autor:
Henry S. Ngu, Laura K Hilton, Kerry J. Savage, Pedro Farinha, David Scott, Alina S. Gerrie, Judith Anula Rodrigo, Kevin W. Song, Graham W. Slack, Diego Villa, Laurie H. Sehn
Publikováno v:
Blood. 138:2499-2499
Introduction Approximately 30-40% of patients (pts) with DLBCL have refractory disease or relapse following R-CHOP. The majority of pts will experience disease progression or relapse early (within 1-2 years), although ~20% experience late relapse >24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c857759b005b576e235252527777bda4
https://doi.org/10.1182/blood-2021-149049
https://doi.org/10.1182/blood-2021-149049